日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy

PANEN列线图：为接受肽受体放射性核素治疗的转移性胰腺神经内分泌肿瘤患者提供临床决策支持

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1514792
Singh, Aviral; Sanduleanu, Sebastian; Kulkarni, Harshad R; Langbein, Thomas; Lambin, Philippe; Baum, Richard P
信号转导
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Prostate-Specific Membrane Antigen Positron Emission Tomography-Detected Intrahepatic Cholangiocarcinoma in a Patient With Metastatic Castration-Resistant Prostate Cancer: Dual Cancer Management With Pluvicto and Intensity-Modulated Radiation Therapy

转移性去势抵抗性前列腺癌患者经前列腺特异性膜抗原正电子发射断层扫描检测到肝内胆管癌：Pluvicto联合调强放射治疗的双重癌症管理

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.90145
Kulkarni, Harshad R; Maupin, Kevin A; Lim, Emerson; Buth, Eric P; Mancini, Brandon R
肿瘤
胆管癌
肿瘤免疫
前列腺癌
发表日期：2025
文献求助 收藏

Dosimetry of [(177)Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial

[(177)Lu]Lu-DOTATATE 在晚期中肠神经内分泌肿瘤患者中的剂量测定：NETTER-1 III 期试验子研究的结果

期刊:
影响因子:
doi:10.2967/jnumed.124.268903
Bodei, Lisa; Cremonesi, Marta; Ferrari, Mahila; Mittra, Erik S; Kulkarni, Harshad R; Deroose, Christophe M; Srirajaskanthan, Rajaventhan; Ramage, John; Grana, Chiara Maria; Botta, Francesca; Weber, Matthias M; Miederer, Matthias; Reddy, Ryan; Chicco, Daniela; Mariani, Maurizio F; Demange, Arnaud; Erion, Jack L; Gericke, Germo; Krenning, Eric
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results

使用 (177)Lu-FAP-2286 进行肽靶向放射性核素治疗多种腺癌的可行性、生物分布和初步剂量测定：首次人体试验结果

期刊:
影响因子:
doi:10.2967/jnumed.120.259192
Baum, Richard P; Schuchardt, Christiane; Singh, Aviral; Chantadisai, Maythinee; Robiller, Franz C; Zhang, Jingjing; Mueller, Dirk; Eismant, Alexander; Almaguel, Frankis; Zboralski, Dirk; Osterkamp, Frank; Hoehne, Aileen; Reineke, Ulrich; Smerling, Christiane; Kulkarni, Harshad R
Human
肿瘤
肿瘤免疫
FAP
发表日期：2022
文献求助 收藏

Prostate-Specific Membrane Antigen Radioligand Therapy Using (177)Lu-PSMA I&T and (177)Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry

使用 (177)Lu-PSMA I&T 和 (177)Lu-PSMA-617 进行前列腺特异性膜抗原放射性配体治疗转移性去势抵抗性前列腺癌患者：安全性、生物分布和剂量学比较

期刊:
影响因子:
doi:10.2967/jnumed.121.262713
Schuchardt, Christiane; Zhang, Jingjing; Kulkarni, Harshad R; Chen, Xiaoyuan; Müller, Dirk; Baum, Richard P
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [(177)Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)

既往治疗作为接受 [(177)Lu]Lu-PSMA-617 治疗的转移性去势抵抗性前列腺癌患者总生存期的预后因素。一项 WARMTH 多中心研究（617 试验）

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-020-04797-9
Ahmadzadehfar, Hojjat; Rahbar, Kambiz; Baum, Richard P; Seifert, Robert; Kessel, Katharina; Bögemann, Martin; Kulkarni, Harshad R; Zhang, Jingjing; Gerke, Carolin; Fimmers, Rolf; Kratochwil, Clemens; Rathke, Hendrik; Ilhan, Harun; Maffey-Steffan, Johanna; Sathekge, Mike; Kabasakal, Levent; Garcia-Perez, Francisco Osvaldo; Kairemo, Kalevi; Maharaj, Masha; Paez, Diana; Virgolini, Irene
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival

间变性甲状腺癌伴脑转移：17 年无进展生存期

期刊:American Journal of Nuclear Medicine and Molecular Imaging
影响因子:1.8
doi:10.1210/jendso/bvab048.1802
Budiawan, Hendra; Salavati, Ali; Kulkarni, Harshad R; Baum, Richard P; Howard, Kathryn Kay; Lapkus, Morta; Luehmann, Natalie; Nagar, Sapna; Czako, Peter
肿瘤
肿瘤免疫
神经科学
甲状腺癌
免疫/内分泌
发表日期：2021
文献求助 收藏

First-in-Humans Application of (161)Tb: A Feasibility Study Using (161)Tb-DOTATOC

(161)Tb首次人体应用：使用(161)Tb-DOTATOC的可行性研究

期刊:
影响因子:
doi:10.2967/jnumed.120.258376
Baum, Richard P; Singh, Aviral; Kulkarni, Harshad R; Bernhardt, Peter; Rydén, Tobias; Schuchardt, Christiane; Gracheva, Nadezda; Grundler, Pascal V; Köster, Ulli; Müller, Dirk; Pröhl, Michael; Zeevaart, Jan Rijn; Schibli, Roger; van der Meulen, Nicholas P; Müller, Cristina
Human
发表日期：2021
文献求助 收藏

Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with (177)Lu-PSMA radioligand therapy

转移程度可预测接受 (177)Lu-PSMA 放射性配体治疗的转移性去势抵抗性前列腺癌患者的生存期。

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.44568
von Eyben, Finn Edler; Kulkarni, Harshad R; Baum, Richard P
肿瘤
前列腺癌
肿瘤免疫
发表日期：2020
文献求助 收藏

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [(18)F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake

PSMA靶向PET显像中[(18)F]DCFPyL的半定量参数：正常器官摄取的患者内和患者间变异性

期刊:Molecular Imaging and Biology
影响因子:2.5
doi:10.1007/s11307-019-01376-9
Sahakyan, Karine; Li, Xin; Lodge, Martin A; Werner, Rudolf A; Bundschuh, Ralph A; Bundschuh, Lena; Kulkarni, Harshad R; Schuchardt, Christiane; Baum, Richard P; Pienta, Kenneth J; Pomper, Martin G; Ross, Ashley E; Gorin, Michael A; Rowe, Steven P
发表日期：2020
文献求助 收藏